kyle laster
China-US (Henan) Hormel Cancer Institute
Zhengzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
China-US (Henan) Hormel Cancer Institute
Zhengzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Palermo
Palermo, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Namur
Namur, Belgium
Review Editor
Pharmacology of Anti-Cancer Drugs
Catholic University of Korea
Seoul, Republic of Korea
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Massachusetts Medical School
Worcester, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
Kyung Hee University
Seoul, Republic of Korea
Review Editor
Pharmacology of Anti-Cancer Drugs
Geisel School of Medicine, Dartmouth College
Hanover, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
College of Oreintal Medicine, Dongshin University
Naju, Jeonnam, Republic of Korea
Review Editor
Pharmacology of Anti-Cancer Drugs
West China Hospital, Sichuan University
Chengdu, China
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Latvia
Riga, Latvia
Review Editor
Pharmacology of Anti-Cancer Drugs
North-West University
Potchefstroom, South Africa
Review Editor
Pharmacology of Anti-Cancer Drugs
Department of Medical and Surgical Sciences, University of Bologna
Bologna, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Minnesota Twin Cities
St. Paul, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Review Editor
Pharmacology of Anti-Cancer Drugs
University of Florida
Gainesville, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, China
Review Editor
Pharmacology of Anti-Cancer Drugs